One such novel subtype, Ph-like acute lymphoblastic leukemia (Ph-like ALL), is characterized by a spectrum of underlying genetic alterations that activate kinase or cytokine receptor signaling, while lacking the BCR-ABL1 fusion gene. The gene discussed is BCR; the disease is acute lymphoblastic leukemia.